Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas
The purpose of this study is to evaluate the efficacy of gemcitabine and cisplatin in Korean patients with biliary tract (bile tracts of the gallbladder or liver) cancer.
Biliary Tract Carcinoma
DRUG: gemcitabine|DRUG: cisplatin
To evaluate the response rate
To characterize the quantitative and qualitative toxicities of gemcitabine combined with cisplatin in this patient population.|To evaluate the following time-to-event efficacy variables: Duration of response, Time to treatment failure, Time to documented disease progression, Overall survival
The purpose of this study is to evaluate the efficacy of gemcitabine and cisplatin in Korean patients with biliary tract (bile tracts of the gallbladder or liver) cancer.